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ABSTRACT 
AN OPTOGENETIC BRAIN-MACHINE INTERFACE FOR SPATIOTEMPORAL 
NEUROMODULATION 
 
by 
Ryan Baumgartner 
 
The University of Wisconsin-Milwaukee, 2014 
Under the Supervision of Professor Ramin Pashaie 
 
Direct neural stimulation has recently become a standard therapy for neurological 
disorders such as Parkinson’s Disease, Essential Tremors, and Dystonia. Currently, deep 
brain electro-stimulation and neuro-pharmaceutical treatments are the dominant 
therapeutic options available to the public. As our understanding of brain function and 
neurological diseases improves, we are able to develop more advanced neuromodulation 
techniques. These methods could become viable treatment solutions for treating brain 
dysfunction. Optogenetics, first introduced by a research team led by Karl Deisseroth at 
Stanford University, has proved to be a versatile technique with remarkable potential to 
be used in treatments for brain disorders, dysfunction, and injuries. Optogenetics makes 
use of light-gated ion channels and pumps, originally derived from certain types of algae 
or bacteria, to bi-directionally modulate the activity of neurons in mammals. By adopting 
new advances in the field of optics and photonics, including high-speed high-resolution 
spatial light modulators, solid-state lasers, and ultra-low noise photodetectors, we can 
build sophisticated devices which allow precise and resolute optical patterning in both the 
spatial and temporal domains.  
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In this thesis, I present an optogenetic brain-machine interface that offers high 
spatiotemporal neuromodulation functionality. The incorporation of imaging and sensing 
devices of neural activity into the system allowed us to run multiple independent 
experiments. These optogenetic experiments include closed-loop modulation of multiple 
areas of tissue, investigating the causal relationship between neural activity and blood 
flow, and quantifying the relationship between neural activity and cell metabolism.  
To understand light to brain tissue interaction in a rat brain, a device has been 
developed which allows one to extract the optical properties throughout the tissue. 
Utilizing this data, Monte Carlo software was used to predict light distribution within the 
brain. This has far reaching effects for the future use of optogenetics. Our approach will 
allow the investigator the ability to precisely understand how introduced light will be 
distributed within the rat brain where light-gated ion channels have been genetically 
expressed. This becomes noticeably important when attempting to determine which areas 
of the brain tissue will and won’t be modulated by the introduced light.  
Due to the many advantages optogenetics inherently provides, it is a rising 
prospect for novel neuromodulation therapies. With continued research and development 
of devices, we could create new therapies for disabilities that arise from dysfunction of 
the human brain. 
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Chapter I. Introduction 
1. Why invest in brain research? 
The human brain is an extremely complex organ. The brain consists of 
approximately 100 billion neurons, and each of these neurons can have thousands of 
connections [1]. Attempting to understand brain function and connections are daunting 
tasks. Scientists’ efforts could potentially yield invaluable information, which may 
impact our lives greatly. It seems that a large collaboration of highly dedicated scientists 
is the only feasible solution to understanding how this biological computer functions. In 
2012, both the United States [2] and European Union [3] announced programs investing 
large amounts of funding towards understanding the brain function, connections, 
processing, and computational brain algorithms. These initiatives were announced 
independently; however, due to the complexity of the human brain, most likely these 
programs will become interdependent.  
These initiatives are designed around the successful “Human Genome Project” [4] 
which not only completed the project goals but exceeded the expectations and had many 
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unforeseeable benefits. Financially, the economic impact was substantial. For every $1 
the US government invested the program returned $141 [5]. The initiative accelerated our 
understanding of Genomics and it also allowed for developments related to bio-
informatics, and aided in research across many fields in medicine and biology. 
With 1 billion people affected by neurological diseases worldwide [6] investing in 
brain research seems imperative. Not only will investing in brain research help people 
suffering from neurological disorders, but it will open new doors for creating complex 
processing algorithms, intelligent machines, or inventing new architectures for complex 
parallel processing units. The brain is a parallel, non-linear processing organ capable of 
cognition. Understanding how our brain is able to understand our surrounding 
environment will benefit humanity greatly, possibly with greater impact compared with 
the human genome project. 
2. Why develop Brain-Machine Interfacing devices? 
The relatively recent computer boom has brought about new opportunities which 
aid in scientist's attempts to understand the human brain. Today, we have a better 
understanding of computation and processing than in the past. Using the innovations of 
computers and programming we have developed algorithmic models of neural networks, 
neural circuits, and brain function which have helped in our quest to understand the brain. 
Even with these algorithmic models, scientists still lack a fundamental understanding of 
human brain function. This disconnection inhibits our ability to cure or treat brain 
disorders and dysfunctions, directly investigate biological networks and circuits in-vivo 
and in-vitro, or to interface directly with our powerful information processing organ 
which is responsible for our well-being. 
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 Using technology and our understanding of the brain, scientists are developing 
tools that are used to understand, communicate, and aid our brains. These brain-machine 
interface devices, which interface or communicate with the brain, have opened many new 
research opportunities and medical treatments that were extremely challenging if not 
impossible before. 
3. Biological Inspired Sciences and Technologies Lab 
Here at BIST labs, we devote our time developing tools which help us understand 
the brain and other biological processes as well as understanding the engineering 
principles adapted for realization of these tools. BIST lab employs the new technique of 
Optogenetics, explained later in this thesis, with a goal of furthering our understanding of 
neural circuitry and brain function. BIST lab’s collaborators are experts in imaging, 
neuroprosthetics, and neuroscience and through our collaborations we create devices that 
potentially aid in brain research. 
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Chapter II. Background 
1. Neural Function 
 The brain is a collection of neurons (electrochemical non-linear biological 
processing cells), which when combined in complex networks with coded data, form the 
ability to understand their surroundings and adapt to win the evolutionary game of life. 
This is a very short yet complex description of the brain. We should start our journey by 
understanding how a single neuron functions. 
In order to understand the most complex processes of the brain we must first 
understand the most fundamental discoveries that explain how a neuron functions. Ions, 
ion channels and pumps, and the membrane potential are all involved in neurons 
function. We should understand these elements to construct our understanding of neuron 
function.  
Ions, ion channels and pumps, the cell membrane, the membrane potential, and 
how these elements work together to create the non-linear function of a neuron are an 
important part of understanding how the brain processes information. Inside and outside 
neurons there is a fluid that consists of many positively and negatively charged ions. In 
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this thesis we will think of ions as point charges, points in space of some positive or 
negative integer value charge. The difference of the net charge of ions inside the cell 
compared to outside of the cell is called the membrane potential. There are many 
pathways or gates located within the cell membrane for these charged ions to enter and 
leave a neuron. We call these pathways ion channels and ion pumps.  
A. Ion Channels and Pumps 
Ion channels are regulated by different mechanisms within the human brain. 
Naturally occurring regulators called neurotransmitters are able to open and close 
transmitter-gated ion channels by binding to neuroreceptors. Alternatively, channels can 
be opened or closed by voltage dependent mechanisms. These voltage dependent 
mechanisms are triggered by specific cell membrane threshold voltages. Certain 
threshold voltages are reached by the concentrated amounts of ions inside or outside the 
cell. This alters the cells membrane potential and triggers the opening or closing of the 
voltage gated ion channel. Transmitter-gated ion channels and pumps are generally 
involved in transferring a signal from a pre-synaptic neuron to a post-synaptic neuron or 
the transfer of signals between neurons. Voltage gated channels are responsible for the 
transfer of a signal within a neuron and triggering the release of neurotransmitters at the 
axon terminals. 
B. Membrane potential  
In order to better understand the function of a membrane potential, we imagine 
that there are three states in which the membrane potential may exist: a resting state, a 
firing state, and a restoring state. Refer to Figure 1 for a visual representation of these 
states with respect to a neuron's membrane potential. 
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C. Resting state  
The resting state is the condition in which the ion concentration inside compared 
to outside the cell has reached equilibrium. At this point, the neuron is ready to receive 
input stimulation from other neurons. These connecting neurons either help to depolarize 
(raise the membrane potential) or hyperpolarize (lower the membrane potential) by 
interacting with the transmitter-gated ion channels located in the neuron’s synaptic sites. 
The dendrites of a neuron may be connected to thousands of neighboring neurons. These 
neighboring neurons have a collective effect on the neuron's membrane potential. 
Neighboring cells can either help to depolarize the cell membrane, bringing the cell 
closer to the threshold voltage, or can help to hyperpolarize the cell membrane, keeping 
the cell membrane potential lower than the threshold voltage. As the membrane potential 
rises due to neighboring cell inputs, it will eventually reach a threshold voltage required 
to open the voltage gated ion channels.  
D. Action state  
When the membrane potential reaches the threshold voltage, the voltage gated 
sodium ion channels open allowing a large influx of sodium ions through the cell 
membrane. After a short period, the slower potassium ions start to open causing an 
outflux of potassium ions. The resulting spike in the membrane potential is called an 
action potential. The duration of an action potential is about 1ms. This action potential 
initiates at axonal hillock and propagates along the axon out to the axon terminals. At this 
point, synapses, located at the ends of the axon terminals, release neurotransmitters in 
order to pass this signal to its neighboring neurons. 
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Directly after this voltage spike, there is a period of time when the voltage gated 
ions are closing and the membrane potential is being restored to the neuron's resting 
 
Figure 1 - A) Image of neuron anatomy. Dendrites receive inputs from connected neurons, the axon is a 
pathway for a neural signal to move from the soma to the axon terminals, the axon terminals and 
synapses are where signal transfer between neurons takes place. B) This is a visualization of the 
membrane potential during the Resting State and the Action State. C) Dendritic inputs are the source of 
inter-neuron communication. The charges of ions entering a neuron as dendritic inputs are cumulative. 
D) Dynamics of the voltage gated ion channels, potassium and Sodium. As the membrane potential 
reaches a threshold voltage, voltage gated ion channels open, causing a spike in the neuron's membrane 
potential called an action potential. The opening dynamics of these ion channels are the main source of 
the action potentials distinct shape. Sodium channels open fast causing an influx of positive ions. 
Potassium channels open and close slower causing outflux of positive ions. When combining the two 
channel dynamics, the net change in ions creates the action potential. Parts of figure adapted from [60] 
and [61] 
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potential (about -65mV). After the neuron returns to its resting potential, the resting state 
of a neuron's membrane potential begins to have an effect on the membrane potential.  
E. Neurotransmitters and communication between neurons 
A post-synaptic neuron is a neuron that has formed a connection through its cell 
body, dendrite, or axon with a pre-synaptic neuron. Neurotransmitters are released from 
the synapse of a pre-synaptic neuron, after an action potential, into the synaptic cleft 
where they are free to bind to neuroreceptors located on the post-synaptic neuron. Each 
type of neurotransmitters bind only to specific neuroreceptors. As these neurotransmitters 
bind with their respective neuroreceptors, the state of the transmitter-gated ion channel 
changes and directly affects the ion concentrations within the post-synaptic neuron. This 
change impacts the neuron's membrane potential, and thus the neuron’s activity.  
Neurons can be excitory neurons or inhibitory neurons depending on the types of 
neurotransmitters they produce. Excitory neurons, when transferring a signal, release 
neurotransmitters that create a flux of ions which have a depolarizing effect on the post-
synaptic neuron. This flux of ions raises the membrane potential, bringing it closer to 
threshold voltage required for an action potential. Inhibitory neurons, when chemically 
transferring a signal, release neurotransmitters that create a flux of ions which have a 
hyperpolarizing effect on the post-synaptic neuron. This flux of ions reduces the 
membrane potential and keeps it further away from the threshold voltage required for the 
generation of an action potential. Both of these neuron types can be part of large groups 
of interconnected neurons called neural networks.  
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2. Neural Networking 
Networks of neurons are self-organizing connections between many neurons 
which, when organized in a particular way, create a data processing apparatus. These 
networks are presented with an input signal that, as it propagates through the network, is 
filtered or coded. The connections in a network of neurons may change over time; this 
ability to change over time is called neural plasticity. These changes can occur because of 
environmental factors, injuries, change in lifestyle, etc. Network function can range from 
simple edge detection within the visual cortex to complex face recognition and motor 
functions.  
Neural networks start their processing using sensory inputs from our sensory 
organs: visual, somatosensory, auditory, gustatory, and olfactory. Each of these sensory 
systems has cells or mechanisms that quantify their specific sense. The visual system uses 
light sensitive cells called photoreceptors, which are present as either rods or cones, to 
quantify photons into neural signals. The auditory mechanism is a collective structure of 
separated air chambers, tiny bones and membranes which are able to separate and 
quantify air pressure waves into their frequency components. The quantification of these 
sensory inputs now becomes inputs to neural networks.  
Each sensory input travels through distinct pathways in the brain. As the signal 
propagates through these pathways the input is processed. This processing extracts 
information from the inputs, which our brain uses to classify our surrounding world. 
These information-processing networks are complex combinations of cells, which have a 
remarkable ability to collectively understand our surroundings through our sensory 
inputs. 
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In order to understand complex networks, we must first understand the simple 
microcircuits that occur within the brain. These microcircuits are the interactions between 
different types of neurons (for example inhibitory and excitory) and different connections 
between them. These distinct microcircuits are considered the building blocks of large 
networks within the brain as they combine and expand to create complex networks with 
specific functions. These complex networks are what enable us to extract and remember 
information from our surrounding environment in order to make decisions.  
Some possible building block microcircuits, or micronetwork motifs are described in 
Figure 2.  
Expanding upon and combining these simple microcircuits allow for the 
development of highly connected and complex networks with specific function. One 
example of the function of these complex networks is edge detection which is used 
extensively in our visual system.  
3. Temporal Firing Rates and Frequency Coding 
Frequency coding or rate coding refers to the phenomenon of information being 
represented within the frequency of neural spikes. An experiment conducted by E. D. 
Adrian, where he stimulated the sterno-cutaneus muscle in a medium sized frog, to 
demonstrate that the frequency of nerve impulses increased as the force on the muscle 
increased [7]. 0.5 grams resulted in a frequency of 35 impulses per second directly after 
loading and after 10 seconds of loading it reduced to 15 impulses per second. 1 gram 
resulted in 66 impulses per second directly after loading and after 10 seconds of loading 
it reduced to 37.5 impulses per second. How information is coded within the brain is still 
an active area of research but it is important for us to remember that information from our 
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surroundings are coded into signals which become the inputs for the neural networks 
within our brains. 
 
 
Figure 2 - Description of possible microcircuits made by combining Inhibitory, excitory, and different 
types of connections between them. This figure is adapted from figure 6 in citation [62] 
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4. Neurons and Oxygen 
Oxygen is crucial to the health of brain cells and these cells receive oxygen 
contained in blood that comes from our lungs. Oxygenated blood is so important to 
functioning brains that our bodies will redirect blood flow to the brain in a case of 
lowered blood oxygen levels. The brain requires approximately 3.3 mL of oxygen per 
100 g of brain tissue per minute [8]. This is roughly 17.82% of our total oxygen 
consumption (Average brain weight *Oxygen consumption per 100 grams brain mass). 
This means that approximately 2.18% of our body weight (Average brain weight/Average 
human body weight) consumes 17.82% of our blood oxygen.  
A widely accepted relationship between neural activity and oxygen consumption 
is that as neural activity increases, oxygen consumption also increases [9]. This 
relationship has become extremely important in brain research due to our ability to 
monitor blood oxygenation easier then monitoring brain activity directly. Functional 
magnetic resonance imaging (fMRI) is a widely used device for monitoring blood 
oxygenation by measuring the blood oxygenation level dependent (BOLD) signal.  
5. Neurons and Metabolism 
The brain needs energy to function! More specifically, the brain needs glucose to 
power its function. Glucose can be incorporated into lipids, proteins, glycogen, and is 
also the precursor of certain neurotransmitters. The brain accounts for 25% of our body’s 
glucose utilization [10]. Just as with oxygen, scientists have formed a connection between 
neural metabolism and neural activity. A widely accepted relationship between neural 
activity and metabolism is that as neural activity increases, metabolism in turn increase. 
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6. Introduction to Neural Modulation 
An important technique that can be used to investigate neural circuitry is 
neuromodulation. We consider neuromodulation as a technique used to control or 
modulate the activity of neurons using an externally controlled source. Today, scientists 
have developed many different types of neuromodulation techniques. These techniques 
use our understanding of neuron function to cause an increase or decrease in neuron 
activity. Having the ability to precisely control the activity of neurons and neural tissue 
allows us the opportunity to correct dysfunction within neural networks in our brains 
[11]. Neuromodulation allows scientists to study the functions of specific areas of neural 
tissue. For example, by stimulating different areas of the motor cortex, scientists have 
developed detailed relational maps between motor (movement) actions and areas of 
neural tissue in the motor cortex [12]. Our understanding of brain function seems reliant 
on our ability to modulate neural tissue. Ideally, a neuromodulation technique would have 
a spatial resolution below the size of a neural cell allowing for spatial targeting in the 
cellular range, and a temporal range of stimulation in the range of a single action 
potential. 
A. Electrical Modulation Technique 
One well-known and widely used technique for modulation of neural tissue is 
electrical stimulation. Scientists use our understanding of electric charge to interact with 
neural membrane potentials. By introducing an electrode of negative charge in an area of 
neural tissue, researchers can stimulate neurons in the surrounding area. Researchers have 
created many different arrays of electrodes with varying size, number of electrodes, 
penetrating and surface mount electrodes, compositions, and electrical designs. While 
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this technique has been used nearly exclusively throughout history for neural experiments 
and treatments for brain disorders, there are many limitations of electrode arrays.  
Electric stimulation can only directly stimulate areas of neural tissue. In order to 
inhibit areas of neural tissue, researchers must indirectly cause inhibition by stimulating 
inhibitory neurons. This seems problematic for neural probing as our knowledge of 
specific neural connections is still vastly unknown. Implanting electrodes into neural 
tissue also poses problems such as damage to tissue, infections, and even our immune 
systems can hinder electrode effectiveness. The sizes of electrode arrays are limited by 
manufacturing processes and also by the amount of damage they cause to the neural 
tissue when implanted. Another issue is that electrode arrays have low spatial resolution 
compared to the size of neurons. 
B. Optogenetics – An optical Neural Modulation Technique 
In 2005, a new technique developed for neural modulation, Optogenetics [13], 
was introduced by the Deisseroth lab at Stanford University. Using genetic techniques, 
Karl Deisseroth and his lab members were able to successfully express DNA, originally 
found in algae, in mammalian neurons. The expressed DNA includes the genetic code or 
instructions for a cell to produce specific opsins. These opsins are light sensitive 
receptors which were used by the algae to sense their source of energy. In neurons, these 
opsins are used to modulate the activity of neurons with light. I will present two specific 
opsins in this thesis, a light-gated cation channel, Channelrhodopsin-2 (ChR2), and a 
light-driven chloride pumping halorhodopsin (NpHR). ChR2, when exposed to light of 
approximately 445nm wavelength (Refer to Figure 3 for a more detailed spectrum of 
stimulation wavelengths for ChR2), allows Na
+
 and Ca
+
 into the cell which raises or 
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depolarizes the membrane potential and leads to an action potential. NpHR, when 
exposed to light of approximately 570nm wavelength, pumps chloride ions into the cell 
which hyperpolarizes the membrane potential thus inhibiting the neuron from firing 
(Refer to Figure 3 for a more detailed spectrum of stimulation wavelengths for NpHR).  
ChR2 and NpHR allow for stimulation and inhibition of genetically targeted 
neural populations on the millisecond timescale [14]. In Figure 3(C), you find an 
experimental demonstration of both ChR2 (neural stimulation) and NpHR (neural 
 
Figure 3 - A) Left image shows channelrhodopsin-2 (ChR2), Right image shows halorhodopsin (NpHR). 
ChR2 allows Na
+
 into the cell when activated by blue light. NpHR pumps Cl
-
 into the cell when 
activated by yellow light. B) Spectral activation of ChR2 and NpHR. Given the maximum locations for 
both are located approximately 100nm from eachother, it is possible to simultaneously stimulate 
using ChR2 while inhibit using NpHR C) Experimental demonstration of both stimulation using ChR2 
and inhibition using NpHR. This figure is directly adapted from “Circuit-breakers: optical technologies for 
probing neural signals and systems.” [63] 
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inhibition). In Figure 3, we notice that NpHR is able to suppress neural action potentials 
even when cells are stimulated with ChR2 and blue light. The development of novel 
optical devices allows for large scale neural network probing with high spatial and 
temporal resolution. The optogenetic technique allows for cell-type specific targeting 
[15] by using appropriate promoters. Another unique benefit of optogenetics is having the 
ability to bi-directionally control the cellular activity of neurons directly. By having the 
ability to express both light-gated cation channels and light-gated anion pumps into 
neurons simultaneously, one has the ability to either increase neural activity or suppress 
neural activity [14][16]. Another benefit of using light as the source for activating the ion 
channels lies within our ability to manipulate light to form images or patterns which are 
both temporally and spatially dependent. In this thesis, I will introduce such a device for 
patterning stimulating light with megapixel resolution and the ability to target specific 
areas contained within the field of view. 
7. Introduction to Neural Monitoring 
Just as important to neuromodulation for investigating neural circuitry is having 
the ability to monitor neural activity or something that indicates neural activity. Current 
techniques and devices used in monitoring neural activity vary widely in both temporal 
resolution as well as spatial resolution. Not only do these techniques vary in resolution 
but they also vary in what specifically they monitor. These monitoring devices measure 
oxygen in blood, the metabolism of cells and tissue, local field potentials, actual 
membrane potential of a neuron, or even the concentrations of calcium inside of a neuron. 
Through years of research and investigation of neural function, scientists have developed 
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and/or are still developing relationships between these neural activity indicators and 
neural activity.  
The functional Magnetic Resonance Imaging (fMRI) technique uses a relation 
between a blood oxygen-level dependent (BOLD) signal and neural activity. Functional 
MRI has become a monitoring device which dominates brain research. Functional MRI 
has acceptable spatial resolution with the ability to monitor the whole human brain. 
Functional MRI has a relatively low temporal resolution mainly due to the nature of 
blood flow within the brain and how blood flow changes in response to neural activity. 
Positron Emission Tomography (PET) monitors the metabolism of neural tissue and uses 
a relationship established between metabolism and neural activity. As neurons are more 
active, the energy usage increases thus metabolism increases. PET machines use this 
intertwined relationship to image brain activity. Electroencephalography (EEG) and 
Electrocorticography (ECoG) both measure local field potentials (LFP) or collections of 
neural activity. EEG measures LFPs from the surface of the scalp while ECoG arrays are 
implanted directly onto the surface of the brain from where they measure LFPs 
originating in the cerebral cortex. Spatial resolution of ECoG is better than EEG's 
resolution because are placed closer to the brain tissue. The membrane potential of a 
neuron can be measured using a technique called patch clamping. The patch clamp 
technique measures the membrane potential by placing one electrode inside the cell while 
having another electrode just outside the cell. The difference between the electric 
potential recorded by these electrodes is the membrane potential. Fluorescence imaging 
allows for measuring changes in metabolism, blood flow, and even concentrations of 
specific ions within neurons. This type of imaging is versatile and has been used for 
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many applications. Pairing fluorescence imaging with neural modulation techniques 
offers additional advantages such as targeting the activity of specific cell types.  
8. Introduction to Brain-Machine Interfacing 
A brain-machine interface (BMI) is a device which interfaces directly with brain. 
There are three possible interactions that can be implemented via BMI application. These 
interactions are monitoring the activity of neural tissue and perform some sort of external 
action, taking input from a person's surroundings and modulate neural activity according 
to this external input (sometimes called a neuroprosthetic device), and modulating the 
activity of one area of neural tissue according to the monitored activity of another area of 
the tissue. The last type of interaction for a BMI can be realized in the form of a closed-
loop BMI device because its interactions are solely within the brain. A BMI device, 
theoretically, can use any type of device which monitors or modulates neural activity. We 
decided to use Optogenetics for neural modulation and Fluorescence Imaging and ECoG 
recording for monitoring when designing our optogenetic brain-machine interface. 
During experiments, with our collaborators at the University of Wisconsin-Madison, we 
integrated a transparent ECoG into the experimental set-up [17].  
9. Neural disorders and Current Treatments 
 The goal of neuromodulation and Brain-Machine interface research is the ultimate 
realization of real world treatments and therapies for neurological disorders, diseases, and 
injuries using any of the various neuromodulation techniques. In order for 
neuromodulation to be described as a therapy, defined by K. M. Alo and J. Holsheimer, it 
must be an ongoing, dynamic intervention that affects specific neural networks and its 
clinical effect is continuously controllable by varying stimulation parameters [18]. 
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Neuromodulation techniques, therefore, can include any method to alter the activity of 
neurons in a controlled manner.  
One of the most developed techniques is Deep Brain Stimulation (DBS) utilizing 
electrodes as the method for altering neural activity. As early as 1969, chronic DBS of 
the thalamus, straitium, and pallidium has been used to treat movement disorders [19]. As 
research in DBS has matured, there have been therapies for essential tremors [20] and 
Parkinson’s Disease [21]. Current neuromodulation therapies for epilepsy include vagus 
nerve stimulation, and DBS [22]. DBS has also provided therapies for neurobehavioral 
disorders such as Obsessive Compulsive Disorder and treatment-resistant depression 
[22]. DBS has had success in relieving chronic pain and neuropathic pain syndromes 
[22]. DBS is also being applied as therapies for Tourette’s Syndrome [23,24], obesity 
[25], dementias [26][27], addictions [28], tinnitus [29], and anorexia [30]. Another type 
of modulation currently used to offer treatments for the management of spasticity and 
pain is chemical. Chemical modulation usually consists of devices which allow chemical 
compounds to pass through the blood brain barrier [22]. 
While these types of neuromodulation have been successful for many types of 
neurological disorders, they lack the ability to control where and which cell types they 
target to modulate activity. Having the ability to stimulate specific types of neurons using 
genetic targeting [15], directly inhibit neural populations [16], or precisely controlling the 
modulating mechanism, similar to what is described in this thesis, could create safer 
therapies for the already established therapies which use DBS, electrical, or chemical 
neuromodulation. Optogenetics, using gene therapy to introduce light-gated ion channels 
into neurons, has many of these advantages which could allow previously not-feasible 
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therapies to be realized. Introduced in 2005, optogenetics is still in the early stages of 
developement and has yet to be fully developed. One exciting prospect is using a spatial 
temporal light projection system to target cortical areas of the brain in order to 
supplement loss of sensory networks which have been disrupted by brain injuries such as 
those caused by stroke. The success of optogenetics will come from its natural 
advantages over current techniques. It seems unlikely that current companies who are 
leaders in neuromodulation device development would stop researching and furthering 
the already developed electrode technologies for therapies which utilize optogenetics. 
However, as long as the limitations of electrodes lags behind the potential for improved 
neuromodulation therapies using optogenetics, there will be a demand to realize the true 
potential of optogenetics. 
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Chapter III. Optogenetic Brain-Machine Interface Design 
1. Design Overview and Design Goals 
 The development of a device which has the ability to monitor neural activity 
and/or biological functions of tissue as well as simultaneously modulate, both inhibit and 
stimulate, neural tissue with a spatial resolution of a single neuron and a temporal 
resolution of an action potential will enable researchers a unique opportunity to 
investigate how the brain networks process information. Understanding how networks of 
neurons process, store, and recall information from our surrounding world appears to be 
an important aspect of brain research.  
Using the newly established field of optogenetics, we now have the ability to directly 
stimulate and inhibit neurons using light. As discussed earlier, using ChR2 and blue light, 
we can open ion channels which allow positive sodium ions into the cell, and using 
NpHR and yellow light we can activate an ion pump which pumps negative chloride ions 
into the cell. Recalling that as a neuron’s membrane potential becomes more positive it 
may reach a threshold voltage at which the cell has a large membrane potential spike 
caused by voltage gated ion channels. This large membrane potential spike passes the 
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signal along the neuron’s axon and to the ends of the dendrites where the signal is 
chemically relayed to post synaptic neurons.  
Not only does using optogenetics and light provide direct and precise control of 
neural tissue modulation, many optoelectronic devices have been developed over the 
years and are used to modulate light spatiotemporally. Using these spatiotemporal light 
modulating devices, we could imagine the possibility of being able to target specific 
neurons or groups of neurons which we would like to modulate. Having an ability to 
target groups of neurons opens the possibility of probing or applying inputs to targeted 
 
Figure 4 – The future hardware design for our Brain-Machine Interface. Each section is 
discussed in depth in the next section. Some features displayed in this image are not available 
with the current implementation. See Figure 15 for the current progress of the device. 
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neurons while avoiding surrounding non-targeted neurons. 
In order to probe neural circuitry, we must be able to record the activity of these 
neurons. Ideally, we would like to record the activity of all neurons simultaneously with a 
temporal resolution similar to that of an action potential. Many functional fluorescence 
molecules have been used to record neural activity [31]. Along with intrinsic 
fluorescence molecules, such as NADH (nicotinamide adenine dinucleotide) and FAD 
(flavin adenine dinucleotide), which are both involved in cell metabolism, there are 
genetically expressed fluorescence molecules which can provide information about the 
membrane potential, or can provide information about ion concentrations within a cell, 
such as calcium indicators. Among these fluorescence molecules, some have the ability to 
function on similar temporal scale as neural action potentials. 
Along with using an imaging path to monitor neural activity, we can use our 
imaging device to make spatial geometrical relations between the location of samples 
which we are imaging and our projection path which is used to modulate the samples. 
These spatial relations make possible our ability to spatially target certain areas of the 
sample. Combining all of these functions: bi-directional neural modulation, monitoring 
neural activity, and targeting, into one device will enable the possibility of methodically 
investigating neural circuitry. 
2. Device Development 
A. Optogenetic Projection Path 
A block diagram of the projection path of the device is illustrated in Figure 5. We 
implement a high powered blue (2 Watt, 445 nm) laser for our optogenetic stimulation. 
The laser beam is homogenized by an integrating rod and collimated by a telecentric 
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illumination lens mechanism before exposing the active area of a Digital Micromirror 
Device (DMD) through a total internal reflection (TIR) prism. The TIR prism, which is 
placed in front of the DMD, guides the beam of light to illuminate the DMD surface at an 
angle of 24 degrees, see Figure 6 according to the specific design of micromirrors on the 
DMD chip. This prism also separates the illuminating beam from the modulated reflected 
beam.  
The DMD (Model – DLP Discovery 4100 0.7 XGA) consists of a 1024 by 768 
matrix of tiny mirrors (13.6 micrometer pitch) which are programmatically controlled to 
reflect projection light into the lens or reflect the light away from the lens. Our DMD 
 
Figure 5 - Projection path block diagram. Laser light originates from the laser. Propagates through the 
homogenizer and diffuser, and then enters the optical engine for the DMD device. The light is then 
spatially modulated and projected through a telecentric lens, beamsplitter #1, and finally the 
objective to the sample. 
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chip can display up to 32,552 binary frames a second or 290 8-bit grayscale images [32] 
[33]. This speed and high resolution allows us to display grayscale images on the same 
time scale of neural activity with megapixel resolution which should allow the device to 
simultaneously modulate a neuron’s activity independently. For our experiments 
presented later, the DMD was used to create pulsed laser trains of spatial photostimulus 
patterns. Rather than modulating the power of the laser, we set it to full power and create 
the pulses by toggling the DMD, effectively creating a pulsed laser signal.  
DMD systems require uniform angles of incidence across the entire modulation 
 
Figure 6 - Digital micromirror functionality on DMD chip. Each one of the 768 by 1024 mirrors can be 
independently controlled to be either on or off. The flat energy state occurs when the DMD is not 
initialized. After initialization, the mirrors enter the off state. 
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screen [32]. To provide this illumination, telecentric illumination architecture is 
introduced directly before the DMD. In telecentric systems, the optical pupil is at infinity. 
This means that the chief rays for each point in the illuminated image field are parallel 
and each DMD micromirror is illuminated with a cone of light incident at the same angle. 
The spatial light modulator which we integrate in our design, DLP4100 by Texas 
Instruments, uses a TIR prism to systematically separate the light from the telecentric 
illuminator and the light reflected by the DMD. All light rays incident on the TIR 
surfaces which are below a specific incidence angle, light from the telecentric 
illuminator, are reflected onto the DMD. The modulated beams are sent back to the TIR 
surface at angles such that they are now transmitted through the TIR prism and into the 
projection optical system.  
In a projector, the illumination optical system, the modulator device, and the 
projection optical system (i.e., the projection lens) form a single complex optical system. 
Each of these three modules optically "interact" with each other and their respective 
designs must carefully adhere to specific interface requirements. When full performance 
is required, the projection lens should be designed specifically for use with a particular 
illumination optical architecture. In our system, we must take into account the 
illumination pupil position, the thickness of the TIR prism and the DMD mirrors, the size 
and resolution of the DMD, and the f/# of the illumination system. 
 The modulated beam, transmitted through the TIR prism from the DMD 
micromirror array, enters a telecentric lens. This telecentric lens ensures that only the 
rays reflecting directly perpendicular with the DMD face enter the system. This is 
important when trying to avoid areas of tissue with the photostimulus light. If light were 
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able to enter the telecentric lens at an incident angle of 24 degrees, the “off” mirror angle 
of the DMD, then stimulus light could possibly excite an optogenetic opsin in a non-
targeted area. The projection optical system accepts these rays of light, transmits, and 
refracts them in such a way as to produce an image of the DMD mirror array surface onto 
a remote screen or at a suitable intermediate image plane to be captured by yet another 
optical system, an image combiner (Photometrics, DC2). The telecentric lens also scales 
down the image created by the DMD by a factor of 2 and projects the pattern on the 
entrance pupil of the image combiner or beamsplitter #1. The image combiner is an 
assembly of mirrors, lenses, and a replaceable dichroic or a beam splitter with two 
polarizers (shown in Figure 5 and Figure 15 as beamsplitter #1).  
Beamsplitter #1 could be any component which has the ability to separate two 
separate sources of light. This component creates a junction between the optogenetic 
projection path and the fluorescence imaging path. Choosing this optical component 
depends solely on your experimental application.  
The first consideration and most important consideration when choosing which 
optical component to use for beamsplitter #1 is the type of optogenetic opsin we intend to 
use during our experiments. Although many new opsins are being discovered, there is 
still a limited selection available and careful consideration should be made when 
choosing an opsin. Our focus when choosing an opsin, on an experimental design level, is 
the opsin’s excitation wavelength and function. The excitation wavelength must be 
reflected to the sample when it comes in contact with optical component #1.  
The second consideration when choosing beamsplitter #1 is the fluorescence 
emission wavelength which will be used for neural monitoring. Depending on the 
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biological process which you would like to investigate, there are many fluorophores or 
fluorescence molecules to consider. There are a wide variety of fluorophores available 
which allow monitoring from many different biological processes such as, vascular 
processes, metabolic processes, neural ion concentration, and cell voltage sensitive dyes, 
all of which can be chosen to fit into your experimental needs. 
When looking at Figure 5, one can notice that the optogenetic stimulating light is 
reflected by beamsplitter #1 while, in Figure 8, the fluorescence imaging wavelength 
propagates from the sample through beamsplitter #1 onto the camera’s sensor. One 
optical component which has this property is a dichroic mirror. One set of beamsplitter 
configurations for the projection wavelength, fluorescence emission wavelength, and 
beamsplitter #1 for the device is displayed in Figure 7. We see that our blue optogenetic 
stimulation light is reflected by beamsplitter #1 while our emission fluorophore 
wavelength is allowed to pass through the component to the camera.  
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Figure 7 - This figure illustrates an example of optical components adapted for our neurovascular 
coupling experiment. Beamsplitter #1, in figure 5, reflects the selected opsin’s stimulating 
wavelength (~445nm) while it allows the fluorescence emission wavelength to transmit through 
toward the camera. Beamsplitter #2, in the same figure, allows for the introduction of the excitation 
wavelength for Rhodamine B isothiocyanate-dextran (Sigma, 70 kDa) while also allowing both the 
opsin stimulating wavelength and fluorescence emission wavelength passing through. 
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B. Fluorescence Imaging Path 
Fluorescence imaging requires 
illuminating fluorescence molecules 
with an excitation wavelength. An 
excitation wavelength source provides 
the energy for the fluorescence 
molecule to emit light of a lower 
energy level. We introduce a 
beamsplitter, beamsplitter #2 in Figure 
8, to deliver light of an appropriate 
fluorescence excitation wavelength 
into the system. This beamsplitter must 
allow the fluorescence signal and the 
optogenetic excitation wavelength to 
pass through while reflecting the 
fluorescence excitation light to the 
sample. We have used one excitation 
source for each of our experiments, discussed in detail later, that involve fluorescence, a 
wide-spectrum high-power light source filtered to a specific wavelength bandwidth and a 
high power ultra violet (UV) LED.  
The wide-spectrum high-power source produces light which passes through one 
of four user specified optical filters. The optical path is controlled by a galvanometer 
mirror that directs the source light to a pair of parabolic mirrors and then injected into a 
 
Figure 8 - Fluorescence imaging path. The excitation 
light for Rhodamine B isothiocyanate-dextran (Sigma, 
70 kDa) is introduced at beamsplitter #2. This 
propagates to the sample. The fluorescence emission 
light is captured through the objective. There is an 
optical filter directly in front of the camera to 
eliminate unwanted light from being imaged by the 
camera.  
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homogenizing light guide. Between these two mirrors, the light passes through a hot 
mirror, to reduce the infrared power, before being filtered by the appropriate optical filter. 
We use sputter-coated high-transmission fluorescence excitation filters which are capable 
of withstanding the absorption of large amounts of optical power from being mounted 
close to the high-power source.  
As the fluorescence excitation light hits the sample, it causes the fluorescent 
molecule to fluoresce emission light which corresponds to a biological process under 
monitor. This emission fluorescence signal propagates from the sample through the 
imaging path eventually becoming incident on an imaging sensor. As this signal 
propagates through the imaging path it passes through a number of components: an 
objective lens, beamsplitter #1 and beamsplitter #2, a collimating adaptor, and optical 
emission filters.  
To ensure the light measured by our imaging sensor is the only light from our 
fluorescence emission signal, we place optical emission filters in the optical path. A high 
speed filter wheel holds the emission filters in place between beamsplitter #1 and the 
imaging sensor within a collimating emission adaptor.  
The collimating adaptor is required for two reasons as demonstrated in Figure 9(a) 
and (b). Anytime a flat piece of glass with a refractive index different from air is inserted 
in a focusing beam, the beam no longer focuses at its original location; instead, the 
location of the focal plane is shifted. The amount of shift depends on the thickness of the 
filter as well as the index of refraction of the glass used to make the filter. The second 
reason is the bandpass quality of the filter which decreases as the incident light’s angle 
changes from 0 degrees. The collimating emission adaptor creates an area of collimated 
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light which allows the addition of other optical devices, such as a filter wheel, without 
sacrificing on the performance or introducing optical aberration, Figure 9(c).  
Many fluorescence molecules, such as NADH, have faint signals; therefore, to 
improve our fluorescence detection capability, we have used an Electron Multiplying 
Charge Coupled Device (EMCCD) as our fluorescence detector. We chose the 
photometrics Evolve 512 EMCCD (photometrics, Tucson, AZ, USA) for its high 
quantum efficiency and ease of integration into our system. The imaging sensor consists 
of a 512 by 512 imaging array while each pixel is 16 by 16 micrometers. The imaging 
sensor can detect light from 350nm to 900nm and at its maximum has a quantum 
efficiency of >95% [34]. 
It is vital that the system, in particular the DMD and the EMCCD, be fully 
synchronized. Any lack of synchronization could cause considerable fluctuation in 
images captured by the EMCCD. This systematic error may be misinterpreted as 
fluorescence changes produced by cellular activities. In order to synchronize all the 
elements of this setup, we have implemented trigger coding throughout the BMI device.  
Focusing of both the imaging path and projection path is achieved by a separate 
lens mechanism, a microscope objective, which is mounted after beamsplitter #2. Our 
 
Figure 9 - Light incident to color filters should be collimated to ensure that the imaging focal plane 
is not affected by the change in refractive index of the color filters. (a) shows the shift in the focal 
plane after a section of glass is introduced in to the system. (b) shows a complication which arises 
from this type of aberration. (c) shows a diagram of one solution to fix this issue which is to 
collimate the light before it passes through the glass section. 
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imaging device is mounted on a three dimensional translation stage in order to center the 
imaged signal and fine tuning of the parfocality between the projection and imaging 
paths.  
3. Device Realization 
 The implemented optogenetic Brain-Machine Interface has demonstrated spatial 
temporal modulation of neural tissue (we have only demonstrated neural stimulation 
using blue light and ChR2), monitoring neural activity using fluorescence, injected dyes 
(vascular response due to optogenetic stimulation) and intrinsic fluorescence (NADH and 
the metabolic response due to optogenetic stimulation), and automated targeting of areas 
 
Figure 10 - Image of the Optogenetic Brain-Machine Interface, designed and implemented in the 
BIST  (Biological Sciences and Technologies) Lab at the University of Wisconsin-Milwaukee, ready for 
experiments at the LOCI (Laboratory for Optical and Computational Instrumentation) lab at the 
University of Wisconsin-Madison 
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of interest using the spatial light modulator (DMD) and simple geometric relations 
between the imaging and projection paths. An actual image of the device is presented in 
Figure 10. 
 In order to test the projection and imaging resolutions of the optogenetic BMI, 
along with a BIST lab coworker (Ryan Falk), we used the 1951 Air Force Resolution 
Target (Edmond Optics, Catalog # NT58-198) to measure the resolution of the imaging 
path. By projecting a uniform pattern of blue light from the DMD and imaging the 
fluorescence given off by the Resolution Target we were able to determine the imaging 
path to have a resolution of approximately 4.38 micrometers [35]. In order to measure the 
projection path's resolution, we uploaded and projected an image of the air force target 
onto a uniform fluorescence sample then we recorded the fluorescence signal through the 
imaging path. Using both the image captured by our camera, the size of the image 
uploaded to the DMD and the BMI's magnification, we were able to determine a 
projection resolution of approximately 4.9 micrometers. The recorded images during this 
process are shown in Figure 11.  
 
Figure 11 - A) The imaging path resolution. Here we imaged the Resolution Target by projecting a 
uniform pattern of blue light via the projection path and recording the fluorescence signal. B) The 
projection path resolution. Here we projected an image of the Resolution Target onto a uniform 
fluorescence sample and recording the fluorescence signal using the BMI's imaging path.  
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Figure 12 - Demonstration of projection resolution and the quality of the imaging path. A) Mask 
for the projected image. Blue projection light will reflect off of the white areas towards the 
telecentric lens and the black areas will be reflected away from the telecentric lens.  B) The mask 
is being projected onto a YFP+ brain slice fixed on a microscope slide. 
 
36 
 
 
 
To demonstrate the combined projection and imaging capabilities of the device, 
we have modulated our optogenetic excitation light to project a masked pattern onto a 
YFP+ brain slice fixed on a microscope slide using a 4X microscope objective. Then, we 
imaged the fluorescence emission light with our EMCCD camera. See Figure 12 for the 
projection mask displayed on the DMD and the resulting fluorescence image.  
The programming which links many devices together to function as one finely 
tuned device for complex optogenetic investigation of neural circuits was programmed 
using LabView and Matlab. One notable program is part of a process called 
“Registration” which makes geometric relationships between the camera pixels and the 
DMD pixels. Figure 13(A) is an approximate drawing of the image which is projected 
onto a uniform sample during the Registration process. Using geometry, the DMD 
coordinates of the four projected “spots” or “corners”, and the captured image from the 
imaging path, Figure 13(B), we can make a close approximation as to the locations of 
 
Figure 13 - A) An approximate drawing of the image which is projected onto a uniform sample 
during the registration process. Using geometry, the DMD coordinates of the four projected spots or 
corners, and the captured image for the imaging path (B), we can make a close approximation as to 
the locations of objects in images captured by the camera. This is how targeting of specific areas or 
combinations of areas possible with our system. 
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objects in future captured images. This is how we have made targeting of specific areas 
or combinations of areas within the camera’s field of view possible.  
Figure 14 demonstrates the targeting ability of the optogenetic BMI. 
Demonstration of automatic cell detection made possible by the registration process 
which, using geometry and known projection masks, relates the camera pixels and the 
DMD pixels. Figure 14(A) shows the imaged fluorescence signal from a pollen grains 
sample while projecting a uniform projection pattern from the DMD, see Figure 14(C). 
We then use a filtering code on the image in Figure 14(A) to automatically extract the 
"objects" and generate an appropriate patterned DMD projection image using the 
previously mentioned registration process which, as we can now see, provides the basis 
for targeting objects in the field of view. Figure 14(C) shows a uniform DMD projection 
pattern while Figure 14(D) shows a patterned DMD projection image which is built to 
target the objects within the field of view optogenetic stimulation light using data from 
the Registration process, see Figure 14(B).  
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Figure 14 - Demonstration of automatic cell detection made possible by the registration process 
which, uses geometry and known projection masks to relate the camera pixels and the DMD 
micromirrors. (A) Fluorescence images of pollen grains while projecting a uniform pattern with the 
DMD (C). (B) Using a filtering code, we automatically extract the "objects" from the image in part (A) 
and generate an appropriate projection pattern (D). The generation of the projection pattern 
requires the DMD to camera registration data.  
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 The current block diagram for our optogenetic Brain-Machine Interface is 
displayed in Figure 15. Beamsplitter #1 and #2 can be customized for various experiments 
which may use different opsins or fluorescence indicators. The camera and DMD can be 
easily related to each other allowing the targeting of areas of interest. We have 
demonstrated the feasibility of incorporating fiber bundles directly after the objective lens 
through various experiments. In Figure 16(left) we see the projection image from the 
DMD through a bundle of 16,000 optical fibers. In the same figure (middle) the same 
fiber bundle is shown sitting next to a mechanical pencil for size comparison. If we 
 
Figure 15 - Current block diagram which was used in the experiments which will be discussed in 
chapter 4. 
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increase the magnification of the external CCD, which is imaging the fiber bundle tip, we 
can see the individual fibers. Attempting to image fluorescence through a fiber bundle is 
difficult since the fluorescence signal is faint. One idea to overcome this obstacle is to use 
a graded-index (GRIN) technology along with a spherical lens to provide a large 
numerical aperture (NA) while keeping loss of resolution to a minimum. In general, the 
larger the NA of a lens the more light it will be able to gather. 
 
4. Micro-ECoG 
Our collaborators at NITRO (Neural Interface Technology Research and 
Optimization) lab at the University of Wisconsin-Madison, microfabricate custom micro-
electrocorticography (micro-ECoG) electrode arrays for measuring the cortical local field 
potentials created by the optogenetic patterned stimulation. Micro-ECoG arrays are 
implanted on top of the dura matter and are therefore useful for localizing cortical activity 
across the surface of the brain. Researchers at NITRO used photolithography to define 16 
platinum electrode sites (150 µm diameter) in a 4x4 grid (0.5 mm site-to-site spacing). 
 
Figure 16 – Left: An image captured from a DMD projected pattern through a fiber bundle which 
consists of 16,000 optical fibers. Middle: Size comparison image of the fiber bundle and a 
mechanical pencil. Right: A magnified image taken of just the wheel. If you look closely you can see 
the individual fibers. 
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They selected Parylene-C, a transparent biocompatible polymer, as the electrically 
insulative substrate, so that photostimuli could be applied to the cortex through the 
transparent device. In chapter 4, we will be discussing many experiments which combine 
both the custom designed micro-ECoG arrays and the custom built optogenetic neural 
modulation DMD platform.  
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Chapter IV. BMI Experiments and Results 
1. Optogenetic Neural Modulation and ECoG Recording 
Our first experiments were designed with the intent to investigate the spatial and 
temporal capabilities of the optogenetic BMI setup by applying a photostimulus to the 
pyramidal cells in the cortex of a ChR2 positive transgenic mouse while monitoring the 
effect on the local field potentials using the NITRO’s micro-ECoG array with a 3kHz 
sampling frequency. NITRO’s micro-ECoG array employs platinum electrodes on a 
biocompatible transparent parylene-C substrate which allows our custom built 
fluorescence microscope to image the fluorescence signals from the brain tissue 
underneath the ECoG. Our collaborators at NITRO lab fabricated the electrode arrays on 
a transparent insulative polymer so that when implanted on top of the dura and under a 
cranial window, photostimuli could still be patterned on the cortex [17]. To investigate 
the spatial functionality of our optogenetic BMI device, we varied two spatial parameters, 
the location and the area of the photostimulus, while keeping temporal parameter, 
photostimulus duration, at 4 ms. In order to investigate the temporal potential of our 
optogenetic BMI device we varied the photostimulus duration while keeping spatial 
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parameters constant. We have employed a digital micromirror device that allows us to 
keep the optical power constant per area and unit of time. Keeping the optical power 
constant per area and time is important when attempting to quantify the stimulation 
caused by a varying photostimulus. 
A. Spatial Experiments 
 We have projected Optogenetic photostimulus patterns with both varying area and 
location on the cortical areas of Thy1:ChR2/H134R-YFP mice while monitoring the local 
field potential (LFP) changes using NITRO’s micro-ECoG array. These first experiments 
were conducted to better understand the spatial distinction of the LFP changes caused by 
the spatially varying photostimulus. We projected many different shapes as well as 
complex patterns of photostimulus with which we avoided the location where the micro-
ECoG electrodes and leads were located. The electrode array is connected to a high-
impedance low-noise amplifier and voltages are recorded referenced to a coil wire 
implanted in the contralateral cortical hemisphere and averaged over 100 trials. In these 
experiments, the cortex is stimulated by 8ms pulses of blue light produced by a 445nm 
laser module which provides 4.5mW/mm
2
 optical power density and 2Hz repetition rate. 
a. Results 
 Figure 17, displays the mapped cortical potentials which were evoked 
optogenetically with varying spatial parameters. The potentials were of greatest 
amplitude near the photostimulus location, suggesting that photostimulus-correlated 
activity is primarily colocalized with the photostimulation location. Stimulating larger 
cortical volumes, Figure 17(B), induced similar amplitude potentials which were spread 
over a larger cortical area. In Figure 17, we have attempted to make visualization of the 
44 
 
 
 
electrode data easier to digest by using a color-mapping system, or heat-maps, which uses 
colors to help the reader visualize the spatial distribution of LFPs measured during these 
experiments. The localization heatmaps in Figure 17 were generated with the spline 
interpolation command of Matlab. 
 
Figure 17 – Visualizations of ECoG’s electrical LFP measurements during spatial experiments. On left, 
an image of the implanted ECoG overlaid with a blue square which represents the photostimulus 
size and location, the white lines are the electrode measurements, and the light blue line represents 
the stimulation duration. On the right, the circles represent electrodes, the blue squares represent 
photostimulus size and location, and the background is a color interpolation. Dark red equates to a 
larger LFP and white represents a smaller LFP. From the data, we can visualize the effects of 
translating the photostimulus as well as scaling the photostimulus size. Figure also used in [64] 
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B. Temporal Experiments 
 In order to understand how the local field potentials (LFP) change with respect to 
temporal variations, we have projected optogenetic photostimulus patterns with varying 
photostimulus duration while monitoring the LFP changes using a micro-ECoG array. 
The temporal experiments were conducted to better understand the temporal distinction 
of the LFP changes caused by varying the duration of a photostimulation. We chose three 
temporal photostimulus durations: 4ms, 8ms, and 24ms.  
a. Results 
 In Figure 18, we can observe the mapped cortical potentials which were evoked 
optogenetically with varying photostimulus durations. The LFPs increased in amplitude 
as the photostimulus duration was increased. Along with this increase in amplitude, the 
LFPs remained elevated for a longer period of time. 
C. Spatial and Temporal Experiment Controls 
 In order to verify that, indeed, the effect observed by the micro-ECoG array was 
caused by the light activation of the ChR2 ion channels, we ran control experiments. 
Having identified the photoelectric effect as a possible artifact which may affect our data 
we decided to run two experiments to help rule out this artifact or show that its effect is 
negligible while implanted on the cortex of a mouse. One control experiment, see Figure 
19, involved implanting wild type mice with electrode to understand the effect a 
photostimulus had in mice which have not been transfected with ChR2 light-gated ion 
channels. The previous experiments conducted by the NITRO lab at the University of 
Wisconsin-Madison studied the photoelectric effect of their transparent micro-ECoG 
while it was submerged in saline solution. Their results concluded that the photoelectric 
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peak was around 5 microvolts which is substantially less than the LFP recorded during 
optogenetic photosimulation during our experiments; see Figure 19. Another control 
experiment consisted of avoiding the electrode sites and leads with the projection light; 
see Figure 20. From the micro-ECoG readings, it is clear that any artifact which may be 
caused by shining light onto the micro-ECoG is negligible. The micro-ECoG 
measurements and stimulation pattern projected while avoiding the micro-ECoG 
electrode sites and traces are in Figure 20. These results show that the recorded potentials 
were nearly the same or negligibly different, ruling out the photoelectric effect as a 
substantial contributor to the results obtained. 
 
Figure 18 – A visualization of the temporal experiments using the optogenetic brian-machine interface. On the 
right, we establish the absolute location of the electrode array, photostimulus, and camera’s field of view with 
respect to the animal’s head. On the left, we can see the photostimulus’ size, shape, and location (light blue 
square), the electrodes measured LFPs (red, green, and blue lines), the start of the photostimulus is located at 
the blue dot, and the photostimulus duration is represented by the varying colors. The blue color is the LFP of 
the 24 mS duration, the green is the LFP of the 8 mS duration, and the red is the LFP of the 4 mS photostimulus 
duration. 
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Figure 19 – Shows the control experiments ran for the NITRO’s transparent micro-ECoG electrodes. 
A) We demonstrate the comparison of micro-ECoG measurements in-vivo between a ChR2 positive 
mouse and a wild-type mouse. This micro-ECoG data clearly shows that the electrode response in 
the ChR2 positive mouse is greater than that of the wild-type mouse. B) Demonstrates the 
photoelectric effect of the micro-ECoG in-vitro in saline solution with varying photostimulus 
duration. We can see that the effect is dependent on the duration of the photostimulus but that 
the electric response is orders of magnitude smaller than what is recorded in ChR2 positive mice. 
Figure adapted from [54] 
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Figure 20 – A direct comparison of a photostimulus pattern which projects on the micro-ECoG 
implant and a pattern which avoids the electrodes and leads of the electrodes with the 
photostimulus excitation light. A) An image of the photostimulus for the solid projection. B) An 
image of the photostimulus projection which avoids the electrodes and leads of the electrode. C) 
Micro-ECoG LFP measurements where the green lines represent the solid projection and the yellow 
lines represent the masked projection which avoids the micro-ECoG electrodes. Using this data, we 
can see that the effect of avoiding the electrodes has only a small and insignificant effect on the 
local field potentials. Figure adapted from [40] 
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2. Closed-Loop BMI using Projection Path and micro-ECoG 
 It's easy to imagine the potential impact of having the ability to modulate neural 
activity using feedback from a reference signal. The reference signal could be the brain 
activity, blood flow, metabolic activity, or even the signal from a sensor which is 
replacing a damaged sensing organ. For example, closed-loop strategies could be 
beneficial in possible treatments of seizures which are an event of abnormal, 
unsynchronised discharge of cortical neurons [36]. Imagine recording from an area of the 
brain tissue known to have abnormal activity discharges while having the ability to 
inhibit the abnormal action potentials within these seizure areas as they become 
overactive. Imagine that important connections within the brain are disconnected due to 
an event such as brain injury or a stroke. Could it be possible to reconnect these areas 
using a device which can modulate one area of the disconnected tissue according to the 
monitored activity of the other disconnected tissue area? Feedback is a necessary 
component of a BMI algorithm which intends to finely adjust the activity of neurons in 
the area of interest within the brain. During the following experiments, we adapted such a 
feedback system using micro-ECoG readings for neural monitoring and our optogenetic 
BMI platform for neural modulation. 
 This section consists of two experiments in which we explore two types of closed-
loop functionality that are potentially valuable for future BMI devices: simultaneously 
controlling the activity of many areas of tissue independently and creating an "Artificial 
Connection" between two areas which otherwise would have minimal neural interaction 
by utilizing the spatial and temporal capabilities of the BMI.  
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A. Micro-ECoG Feedback Mechanism 
 The feedback mechanism employed throughout the closed-loop experiments 
consists of a simple negative feedback loop described in Figure 21. The most critical 
parameter of the feedback mechanism is the proportionality factor, Kp. Kp is the scaling 
factor for the time duration of the stimulation signal projected onto the tissue from the 
DMD device. Using this simple feedback system, we were able to conduct a few closed-
loop experiments which monitor the local field potentials using the micro-ECoG from 
NITRO’s lab and stimulating the pyramidal neurons in the cortex of transgenic mice 
using our custom built DMD neural modulation platform. In Figure 22, we examine the 
 
Figure 21 – A) A schematic of the closed-loop brain-machine interface algorithm. This closed-loop 
system works by introducing an optical neurostimulating signal using the brain-machine interface 
and uses NITRO’s micro-ECoG electrodes to measure the LFPs of differing areas of tissue. This 
measurement is compared to a set-point and then an error signal is sent to the DMD in the form of a 
analog voltage which is related to a specific photostimulus duration. B) Shows the exact algorithm 
used in our closed-loop brain-machine interface. Figure adapted from [64] 
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consequences of varying the value of the proportionality constant. 
 
B. Multiple Area Independent Modulation 
 The motivation for conducting this experiment is to demonstrate an ability to 
increase the neural activity of four areas by varying the photostimulus duration according 
to the previous sequence's electrode signal at each location. This experiment can be 
viewed as a precursor to more complicated experiment where activity levels over space 
are kept at their variable set points throughout time. In these experiments, we hope to 
create patterns of activity that are variable over time and space resembling the recordings 
from fMRI. Due to current digital signal processing limitations, we could only read and 
filter neural signals from 4 electrodes during this experiment thus limiting the number of 
electrodes that could be observed in real-time.  
 
Figure 22 – An experiment which demonstrates the effects of varying the proportionality constant (Kp). 
The top graph shows the ECoG measurements (in green), set point (in blue) with respect to time which is the 
bottom axis of all graphs. The middle graph shows the duration of each photostimulus at each time. The 
bottom graph displays the value selected for each Kp variable at each time. In the top graph, we can see 
instances where the system is underdamped (0 s to ~250 s), overdamped (~250 s to ~350 s), and critically 
damped (~350 s to ~450 s). Figure adapted from [64] 
 
52 
 
 
 
 
  The multiple area independent modulation experiment was designed to modulate 
the activity of 4 areas of tissue around electrodes from the base level activity to 
independent pre-chosen neural activity set points (see Figure 23) using feedback from 
 
Figure 23 – Visualization of a complex spatio-temporal closed-loop neuromodulation experiment. 
The upper left image shows the location of the photostimulus (the black square) and the 
photostimulus’ related electrode number. The bottom row, which consists of three images, is the 
temporal sequence of applied photostimulus projection locations. The sequence of masks applied is 
as follows, projection mask #1 is available for projections for 100 ms, then projection mask #2 is 
available for projections for 100 ms, then projection mask #3 is available for projections for 100 ms, 
followed by a period of 700 ms when no projection mask is available for projection. This sequence is 
repeated for hundreds of seconds, data of which is displayed in the top right image. The top right 
image shows the measaured micro-ECoG values (in green) of all four electrodes involved in the 
closed-loop experiment, the activity set-point (in blue) for each of the four electrodes, and the 
photostimulus duration (in red), all through time which is the horizontal axis of the graphs. From 
this data, we can see that our spatio-temporal BMI has the ability to control multiple points which 
follow independent set-points over time. Figure adapted from [64] 
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each electrode recorded during the previous stimulation sequence. The feedback signal 
allows the adjustment of our photostimulus duration, either longer or shorter, according 
to the reference set points. Using feedback, we were able to raise the level of activity to 
the set point level within a relative proximity of its associated set points by adjusting the 
feedback parameters (see Figure 23).  
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Figure 24 – (Top Image) An image visualization of the 4 point closed-loop BMI experiment. This 
image consists of an intensity color (black equals little to no activity while white equals most 
increased activity) for all 157 sequences of the experiment. The electrodes which correspond 
to a given photostimulus are identified by the red rectangles and the square # located to the 
right of the image. The middle image is a visualization of the projection sequences. The bottom 
diagram is a block diagram of the electrode signal filtering and processing. 
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C. “Artificial Connection” Between Two Neural Areas 
 The “artificial connection” experiment which I present is motivated by the ability 
to connect two “sites” of the brain tissue which otherwise would not have been connected 
or have been disconnected due to brain injuries or diseases. In Figure 25(a), we can view 
the physical location of the two sites which we intend to “connect”. The two sites are 
placed sufficiently far away from each other to minimize the cross talk of the local field 
potentials picked up by the micro-ECoG electrodes. The procedure for this experiment is 
as follows: Site 1 is programmed to follow a predetermined electrode activity set point 
where the tissue’s activity is modulated by the optogenetic DMD stimulation platform 
and the feedback system with a proportionality factor (Kp) the same as described earlier 
in the multiple area independent modulation experiment. Site 2 is programmed to follow 
the electrode measurement of site 1’s activity caused by the previous stimulation. This 
essentially creates an artificial connection between these previously minimally connected 
areas of cortical neural tissue.  
 Looking at Figure 25(b), we can observe the electrode measurements at site 1 and 
site 2 as well as the activity set point of site 1. While observing the results in Figure 
25(b), it shows that the site 1 (blue line) roughly follows the set point (black line), and we 
also see that site 2 (green line), slightly lags, or follows site 1’s LFP measurement (blue 
line). 
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3. Optogenetic Investigation of Neurovascular Coupling 
 The experiments we designed to investigate the causal relationship between 
neural activity and hemodynamics within brain tissue are of clinical and experimental 
interest. Optogenetics is a great tool to investigate this relationship. A temporal 
correlation has been established between LFPs and the BOLD signal recorded by fMRI 
machines [37]. Another interesting result in using optogenetics to investigate the 
relationship between neural activity and hemodynamics is to understand how optogenetic 
stimulation relates to hemodynamics. Benefits of using the custom projection device and 
optogenetics to investigate hemodynamics is the cell type specificity and a direct route to 
recruiting activity as well as the spatial patterning of stimulating light. Blood flow 
changes in response to optogenetic stimulation have been previously described [38]. This 
experiment provides a novel approach for studying neurovascular coupling by imaging 
 
Figure 25 – The “artificial connection” experiment. This experiment is an experiment which was run 
to grasp the feasibility of bypassing nonfunctioning tissue within the cortex. In this experiment, we 
used a feedback system where the electrode measurements controlled the projection durations of 
photostimulus. The overall process is as follows: Site 1 is programmed to follow the set-point and 
site 2 is programmed to follow the electrical activity measurements from the electrode located at 
site 1 thereby allowing the activity signal from site 1 to be transferred to site 2 without these two 
locations being previously associated with each other. (b) It can be observed that the activity of site 
1 follows the set-point, while site 2 slightly lags the activity of location 1 or location 1 follows the 
electrode measurements from location 2. This figure is adapted from [64] 
 
57 
 
 
 
cerebral blood vessels in-vivo while applying photostimulation to the cortex through a 
thinned-skull window in Thy1-ChR2/H134R mice [39] using the previously described 
optogenetic projection device, see Figure 15, and an intravenal dye, Rhodamine B 
isothiocyanate-dextrane (Sigma, 70 kDa). For more specifics on the animal protocol refer 
to [40]. 
A. Experimental Procedure 
Epifluorescence images of the cortical surface were collected at 7 frames per 
second. Mirror #1, see Figure 15, was a dicroic with longpass cutoff at 500 nm. We used 
a 50%-50% beam splitter for mirror #2. Rhodamine B was excited with green light 
(550/40 nm, 1 mW total power) from a xenon light source (DG-4, Sutter) and a red 
emission filter 630/50 nm (Chroma) was positioned in front of the camera. During each 
trial, the vessels were imaged for 10 seconds prior to the photostimulus and 30 seconds 
following the stimulus. The photostimulus (4.5 mW/mm
2
, 445 nm) was applied for 1 
second and pulsed at 25 Hz (20 ms on, 20 ms off). Trials were repeated every 1 to 2 
minutes, and 7 trials were done for each photostimulus pattern. 
To determine vessel diameters, measurement locations were specified on each 
vessel manually and a band was defined along the axis of the vessel over which the data 
were spatially averaged. The vessel width was measured as the full width at half-
maximum, and a 3 point median filter and 3 Hz low pass filter were applied similar to 
Drew et al. [41].  
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B. Results 
Branches of the middle cerebral artery (MCA) dilated transiently following 
photostimulation (25 Hz x 20 ms for 1 second, 4.5 mW/mm
2
, 445 nm) of the cortex, see 
 
Figure 26 – Quantification of blood vessel diameter expansion in response to optogenetic 
photostimulus in ChR2 positive mice. Three spatially varying photostimulus masks were used to 
stimulate the cortical neurons within a mouse (a-c, overlaid in blue). The photostimulus was applied 
as a pulse train with irradiance held constant (20 mS pulsewidth at 25 hz for 1 Sec, 4.5 mW/mm2, 
445nm wavelength). The average image of prestimulus recordings is shown as the gray image and 
the post stimulus percent change overlaid in red (a-c). From this data, the large (a) and medium (b) 
photostimuli caused the middle cerebral artery branches to dilate, while the veins showed minimal 
response. (d) Arteries are labeled a1 and a2 while veins are labeled v1 and v2. (e) Measured 
diameter values of the middle cerebral artery branches (a1 and a2) showed a 30% increase following 
the large area photostimulus, while the medium area photostimulation caused a 15% diameter 
increase, and the small photostimulus caused minimal dilation. In comparison to the arteries, the 
venous response (v1 and v2) was smaller and seemed to return to basil value slower. Seven trials of 
each stimulus were conducted per animal. (f) The study was replicated in 4 ChR2 positive mice and 4 
wild type mice, and the median percent change of the MCA was significantly larger (p = 0.014) in the 
ChR2 positive mice than in the wild type at the alpha = 0.05 confidence level (one-tailed signed rank 
test). Figure adapted from [40] 
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Figure 26, recovering to prestimulus diameters after several seconds. The hemodynamic 
response was robust, occurring in every individual trial. While branches of the MCA 
dilated more than 30% for the large photostimulus, nearby veins showed a much smaller 
and somewhat delayed response.  
The magnitude of both the arterial and venous response depended on the cortical 
area excited optogenetically. We used the microprojector to create photostimulus patterns 
of different areas while holding optical power per area (irradiance) constant. The smallest 
photostimulus evoked little to no hemodynamic response, while the two larger 
photostimulus patterns evoked proportionate responses.  
C. Neurovascular Coupling Control Experiments 
As light is absorbed by tissue, there is a transfer of energy in the form of heat. 
There were concerns that this increase of tissue temperature could have introduced an 
artifact. Also, some fMRI artifacts have been reported in wild-type (WT) rodents at high 
photostimulus levels [42,43]. In response to these concerns, we replicated our study in 
both ChR2 expressing (n=4) and WT (n=4) mice, Figure 27. The median arterial response 
to the large photostimulus was significantly (p=0.014) larger in ChR2 than WT mice, see 
Figure 26 and Figure 27.  
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We utilized the full capacity of the microprojector to investigate whether direct 
photostimulation of the major cerebral vessels is responsible for the hemodynamic 
response, see Figure 28. We explored this potential artifact, because if perivascular 
nerves express ChR2, then a direct cholinergic mechanism could explain the optogenetic 
hemodynamic response. We applied a solid photostimulus pattern, Figure 28(a), and a 
 
Figure 27 – Quantification of blood vessel diameter expansion in response to optogenetic 
photostimulus in wild type mice. Three spatially varying photostimulus masks were used to 
stimulate the cortical neurons within a mouse (a-c, overlaid in blue). The photostimulus was applied 
as a pulse train with irradiance held constant (20 mS pulsewidth at 25 hz for 1 Sec, 4.5 mW/mm2, 
445nm wavelength). The average image of prestimulus recordings is shown as the gray image and 
the post stimulus percent change overlaid in red (a-c). From this data, there was a relatively small 
arterial diameter increase for all sizes of photostimulus and the veins showed no change. (d) Arteries 
are labeled a1 and a2 while veins are labeled v1 and v2. (e) A small artifact was observed following 
the photostimulation, but the aplitude was always much smaller in wild type than in ChR2 positive 
mice (see Figure 26). Figure adapted from [40] 
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pattern with the major cerebral vessels removed, Figure 28(b). The resulting 
hemodynamic responses, Figure 28(d), were similar. Had perivascular nerves been 
involved, we would have expected a disproportionately smaller hemodynamic response 
for pattern with vessels omitted. These experiments, see Figure 28 andFigure 29, suggest 
that projection is necessary for observed hemodynamic response, and direct projection 
onto the measured vessels cannot account for the observed hemodynamic response. 
 
 
Figure 28 – Quantification of artifacts caused by projecting high intensity laser light directly onto the 
blood vessels. (a) We projected a solid square and (b) a pattern where the blood vessels’ locations 
were masked. Other photostimulus parameters were 20 mS pulsewidth at 25 hz for 1 Sec, 4.5 
mW/mm
2
, 445 nm were held constant. The blood vessels were measured at the locations labeled 
(a1, a2, v1, and v2) in (c). (d) The hemodynamic response was similar for the solid and masked 
photostimulus patterns. Figure adapted from [40] 
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4. Optogenetic Investigation of Neurometabolic Coupling 
A. Experimental Procedure 
We imaged NADH (nicotinamide adenine dinucleotide) fluorescence intensity 
using standard (single photon) excitation. NADH has an excitation peak near 350 nm and 
an emission peak near 450 nm. We used extremely low levels of UV (ultra violet) light to 
minimize UV damage to the cortex and to avoid excitation of ChR2. 8 µW/mm
2
 has been 
suggested previously as a safe level for prolonged in-vivo NADH imaging [44]. We used 
a UV LED (365 nm, Thorlabs) and an OD1 neutral density filter (Thorlabs) to reduce the 
light level to 8 µW/mm
2
. At this level, we observed no photobleaching of NADH, and the 
light intensity is orders of magnitude below what could possibly excite ChR2. Using the 
EMCCD camera made the imaging of such a faint signal possible. 
 
Figure 29 – Quantification of diameter size comparing normal projection using the optogenetic 
brain-machine interface and a blank projection (or no projection) with the optogenetic BMI. The 
blood vessels show no change with the DMD chip projecting no mask while the high powered laser 
is still operating. This basic control demonstrates the necessity of providing blue light to the cortex 
to have an optogenetic response. Figure adapted from [40] 
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B. Results 
We imaged NADH fluorescence intensity as a signature of the metabolic status of 
the cortex following ChR2 photostimulation (445 nm, 4.5 mW/mm
2
, 5 ms x 66 Hz for 1 
second). When oxidized, NADH, an endogenous fluorescent protein involved the citric 
acid cycle, glycolysis and other metabolic pathways, becomes NAD+, which doesn’t 
fluorescence. The NADH signal decreased by about 4% following photostimulation and 
it recovered over several seconds, see Figure 30.  
This effect was not observed in WT mice; see Figure 30(g) and Figure 31. Similar 
to the vascular experiment, the peak amplitude of the NADH response depended on the 
area of stimulation. 
 
 
Figure 30 – Metabolic increase following ChR2 photostimulation. Nicoadenine dinucleotide (NADH) is 
involved in cellular metabolism. When cell metabolism increases, NADH is oxidized to NAD+. NADH 
fluoresces while NAD+ does not. In this experiment, we imaged this fluorescence signal before and 
after ChR2 stimulation (5 mS pulsewidth at 66 hz for 1 second, 4.5mW/mm
2
, 445 nm) of different 
cortical areas. A large decrease in the fluorescence signal (f) of the region of interest (ROI) displayed 
in (e) for the large stimulus area (d) while for the smaller photostimulus area (a) there was a smaller 
response (c) within the ROI (b). 10 trials were conducted for each photostimulus pattern per animal. 
The study was replicated in 3 ChR2 mice and 3 wild type mice with the peak fluorescence change for 
the large photostimulus plotted in (g). A p-value of 0.05 was found for a one-tailed signed rank test. 
Figure adapted from [40] 
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Figure 31 – Control data for the NADH experiments using wild type mice. While projecting a small (a) 
of large (d) photostimulus onto the cortex of wild type mice there was no changed observed in the 
NADH fluorescence intensity (c) and (f). Blood vessels were excluded from the ROIs (b) and (e). Figure 
adapted from [40] 
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Chapter V. Predicting Light Distribution within the Brain Tissue 
1. Motivation 
 Using light-gated ion channels in optogenetic neuromodulation allows for 
unprecedented spatial and temporal control of the activity of neural tissue within cortical 
areas of the brain. It is known that these optogenetic light-gated ion channels require 
adequate optical stimulation to cause neural spiking. Therefore, it is essential to have the 
ability to predict light intensity distribution within tissue. It is important to determine, 
given some optical input, which areas of tissue could receive adequate optical stimulation 
power to cause an optogenetic reaction. It is also important to determine which areas will 
receive inadequate optical power to cause an optogenetic reaction. Another important 
consideration, while using optogenetics, is limiting optical stimulation power to levels 
below the photo-bleaching or photo-damage threshold of the tissue. Finally, it is known 
that biological mediums, such as the brain tissue, are inhomogeneous, turbid, and 
anisotropic which introduce problems with the assumption that the tissue is homogeneous 
or isotropic.  
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With these considerations in mind, we have developed a procedure to extract the 
optical properties of rat brain tissue. With these optical properties, we assembled a 3-D 
tool with which investigators could run Monte-Carlo simulations to determine the optical 
distributions within the brain tissue before applying optical neuromodulation. This 
enables them to ensure that they are not damaging tissue in the stimulation area, that they 
are applying adequate stimulation power to the targeted area, and also allows them to 
knowingly avoid stimulating volumes of the brain tissue deemed necessary to avoid.  
2. Custom Device for Extraction of Optical Properties in Brain Tissue 
 The optical properties of the brain tissue are typically described in publications by 
three variables: the absorption coefficient, the scattering coefficient, and anisotropy factor 
[45]. In order to calculate the optical properties of the tissue, we need to measure three 
values from voxels within the volume of brain tissue. These measurements include 
ballistic transmittance, diffuse reflectance, and diffuse transmittance [46]. The diffuse 
reflectance and diffuse transmittance measurements were aquired simultaneously using 
setup #1 in Figure 32 which uses two integrating spheres. This is a standard for acquiring 
these measurements [47]. The ballistic measurements were obtained using the setup #2 
described in Figure 32.  
 Our approach for measuring the necessary data to calculate the optical properties 
of brain tissue required the following procedure. We scanned 500 micrometer thick slices 
of fresh Sprague-Dawley rat brain tissue at a resolution of approximately 3000 points per 
square centimeter for three different cuts (sagittal, transverse, and dorsal) and three 
different wavelengths (405 nm, 532 nm, and 635 nm). The three different cuts cover 
anisotropic factors and the three different wavelengths cover changes through the visible 
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Figure 32 – Schematic of the experimental setups used to measure diffuse reflected and transmitted 
light (Setup 1), and the transmitted ballistic light (Setup 2). This figure is directly adapted from 
“Extraction of optical properties and prediction of light distribution in rat brain tissue.” [65] 
spectrum. As fresh slices were cut with a vibratome (Lancer vibratome Series 1000), we 
immediately scanned the brain slices using setup #1. After scanning each slice, we 
covered them with a saline solution and placed them into a fridge to preserve them. After 
the whole brain was scanned, we transformed the scanning device to setup #2 and 
proceeded to re-scan each slice to obtain the ballistic transmittance data. When all three 
measurements were obtained, we used the inverse adding doubling (IAD) algorithm [46] 
to reconstruct the optical properties from the raw data. By mapping the optical properties 
to an atlas of the brain, a 3-D database of tissue optical properties was established. Next, 
using this 3-D database, we ran Monte Carlo analysis to simulate light-tissue interactions 
to determine the distributions of light within the brain tissue.  
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3. Monte Carlo Light Distribution Simulations 
In Figure 36, we ran simulations by employing our 3-D Monte Carlo toolbox [47,48] 
to demonstrate the effects of using different light delivery parameters such as the optical 
fiber diameter, wavelength, optical fiber numerical aperture (NA), and the beam profile 
of the light source, see Figure 36. We ran simulations using the Monte Carlo toolbox to 
present the impact on axial fluence at varying depths by placing an optical source at 
different locations on the cortex of the brain tissue. The simulation results are shown in 
Figure 35. 
 
Figure 33 – The steps of Setup #2’s procedure. Part (A) shows an image taken at the beginning of 
each ballistic experiment. Image processing is applied to the image to extract the slice. Software 
was developed to find which voltages to apply to the galvo mirrors which then are fed into scanning 
software. There are either 16 or 25 images taken during the scanning of each slice, see (B). Part (B) 
shows the ballistic data which is automatically extracted using developed software. All of the data 
for each slice is combined and interpolated to get an image, see part (C). Each successive slice can 
then be stacked to create a three dimensional database, see part (D). 
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Figure 35 – (A) Optical fibers with 100 micrometer diameters are placed on the regions marked ‘A’ 
and ‘B’. (B) Using data obtained in these extraction experiments, we can simulate the axial fluence 
rate along the z axis for different locations of the brain, in this case, ‘A’ and ‘B’. The difference 
between the attenuation coefficients in these locations causes significant difference in the depth 
which the 405nm blue laser light could penetrate. This figure is directly adapted from “Extraction 
of optical properties and prediction of light distribution in rat brain tissue.” [65] 
 
 
Figure 34 – A visualization of a Monte Carlo simulation overlaid onto the corresponding slice within 
a brain atlas. 
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Figure 36 – (A) shows the location an optical fiber which is being used as an input parameter for 
monte carlo simulatation software that implements our measured tissue properties which is used to 
investigate the effect of source parameters on the distribution of light within the brain tissue for 
405nm laser light. (B) shows the effect of varying fiber diameters, (C) shows the effect of varying 
fiber numerical apertures (NA), (D) shows the effects of varying laser wavelengths, and (E) shows 
the effect of the beam profile on the axial distribution of light. This figure is directly adapted from 
“Extraction of optical properties and prediction of light distribution in rat brain tissue.” [65] 
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Chapter VI. Outlook for Optogenetic BMI devices and Experiments 
1. Benefits of using light-gated ion channels for neuromodulation 
Optogenetics has quickly become a well-known and widely used 
neuromodulation technique for the study of the nervous system in animal models. The 
success of optogenetics could be attributed to the large number of advantages this 
technique offers compared with classical techniques, such as chemical [50] and electrical 
stimulation [50,51]. The optogenetic technique allows for cell-type specific targeting [15] 
by using appropriate promoters. Another benefit of optogenetics is having the ability to 
bi-directionally control the cellular activity of neurons directly. By expressing both light-
gated cation channels and light-gated anion pumps into neurons simultaneously, one can 
either increase or suppress neural activity [14,16]. Another benefit of using light for 
activating neurons lies within our technological tools which have been developed to 
manipulate light to form images or spatiotemporal patterns. As the design of these 
optogenetic BMIs are improved, they will play an important role in the development of 
complex experiments which add to our understanding of the brain. These devices will 
allow scientists to investigate neural circuitry in new ways and create complex treatments 
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for brain conditions where stimulation or inhibition is needed on the cortical surface. 
Examples of treatments where optogenetic BMIs could surpass current treatment 
technologies are allowing profoundly blind patient sight or enabling movement in 
severely immobilized limbs caused by brain malfunctions [53]. These deficits require 
complex neuromodulation in order to replicate the sensory input or the physical output of 
a normally functioning brain. Electrode arrays, which are currently being used for these 
purposes, have severe limitations which can be avoided by using optogenetics as the 
source of neuromodulation. As electrodes are implanted, they can cause a considerable 
amount of damage to the brain tissue. Limitations within the manufacturing process set 
limits on how many electrodes can be mounted onto a chip and how small the electrodes 
can be. In the next section I will introduce some light deliver systems which could be 
used in future optogenetic BMIs.  
2. Future Optogenetic BMI designs and Experiments 
There have been many light delivery mechanisms introduced as potential future 
 
Figure 37 – Various techniques and devices developed or currently being developed to deliver light 
to areas within the brain in-vivo. (a) shows a basic implantation of a fiber optic in brain tissue in 
order to deliver therapeutic optogenetic light to areas deep within brain tissue. (b) shows a rat 
which has two implants. (c) shows the structure of a multichannel waveguide [57], and (d) shows 
an array of multichannel waveguides [56]. (e) shows a side-firing fiber which uses refraction to 
radiate light at near orthogonal angles (developed at BIST labs) [55]. (f) and (g) show a 
microactuator assembly  which is able to translate optical fibers to different depths within brain 
tissue [55].  This figure is directly adapted from “Optogenetic brain interfaces.” [54]  
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delivery mechanisms for varying experimental and procedural applications [54]. The 
simplest mechanism is a single optical fiber implanted stereotactically into target areas 
either shallow or deep within the brain, see Figure 37(a and b). By altering the tip of the 
optical fiber, one can direct the optical power nearly orthogonal to the fiber so that light 
is emitted in a side firing fashion, see Figure 37(e) [55]. This would be valuable where a 
treatment calls for stimulation or inhibiting light which is needed at different depths in 
the brain. Adding multiple optical fibers together or creating multiple channel 
waveguides introduces one could introduce different wavelengths in different areas or 
different depths [55,56]. This would be valuable where a treatment calls for differing 
stimulation or inhibiting light sources are needed at different depths or locations within 
the brain. Micro-actuator assemblies have been developed to move side firing fibers 
inside the brain in a direction perpendicular to the surface of the skull, see Figure 37(f 
and g) [55]. This device was designed to be used with some type of side-firing optical 
fiber so that one could modulate different layers within the brain. 
Continuing to more complicated designs, we examine spatial light modulator 
(SLM) systems which include the device introduced in this thesis. Using these light 
modulating devices one can directly target areas on the surface of the cortex with great 
spatial and temporal resolution. As introduced in this thesis, one could develop a system 
which utilizes a DMD SLM, see Figure 38(a). Another SLM which was not introduced is 
liquid crystal technology which is fundamentally designed to be used with coherent light 
sources. These light modulators work by introducing a spatial phase shift which, in turn, 
introduces interference patterns creating spatially varying levels of optical power. For a 
simple block diagram of a liquid crystal design, see Figure 38(b). The block diagram 
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presented displays SLM systems which couple with fluorescence imaging systems to 
allow for monitoring of introduced opsins and/or monitoring the neural activity within the 
field of view. Advances in SLM technology could allow for the miniaturization of these 
designs allowing systems small enough to be feasibly implanted onto the surface of the 
skull allowing a patient the ability to be actively moving while wearing the optogenetic 
BMI device.  
 
Figure 38 – Two different spatial light modulator designs  for optogenetic modulation. (a) shows a 
design for a DMD based system for both optogenetic modulation and fluorescence and wide field 
imaging. This is the design which was implemented in this thesis. (b) shows a design for a liquid 
crystal based system for optogenetic light delivery and holographic microscopy. This figure is 
directly adapted from “Optogenetic brain interfaces.” [54]  
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Developing a device which combines projection technologies with brain imaging 
systems allows for many more brain-machine interface device designs. Initial imaging 
devices used in neuroscience measured the electrical activity of the brain tissue. Over 
time, these technologies have evolved to more complex and accurate measuring tools. As 
stated earlier, patch clamp technology allows for the measurement of the membrane 
potential form a single neuron. An electrode can measure the local field potential of the 
surrounding tissue while an array of electrodes can measure multiple LFPs within tissue. 
Moving from electrodes to more abstract measurement techniques, fluorescent indicators 
fluoresce with different intensities depending upon the electric potential. As presented in 
this thesis, one could use blood flow or blood vessel diameter as an indicator of neural 
activity as well as intrinsic fluorescent molecules which are directly involved in cell 
metabolism such as NADH or FAD.  
Combining these many types of optogenetic neuromodulation techniques with the 
many brain imaging systems opens possibilities for new experiments. These new 
experiments could help to provide insight into the workings of neural circuits, neural 
function, or maybe neural circuit development. Using optogenetic modulation while 
monitoring activity within the brain using fMRI could be of great importance for a simple 
fact that fiber optics are compatible with the fMRI design. With optogenetic research in 
its infancy, there are many opportunities to think of novel experiments which could prove 
to be of great importance to neuroscience and the collective understanding of how our 
brains function.  
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Chapter VII. Concluding Remarks 
 The optogenetic brain-machine interface and light distribution simulation tools 
developed during my collaboration with the Laboratory of Optical and Computational 
Instrumentation (LOCI), Neural Interface Technology Research Optimization Laboratory 
(NITRO), and members of the Bio-Inspired Sciences and Technologies laboratory 
(BIST). Notably, from BIST labs, Mehdi Azimipour, Ryan Falk, and of course, my 
advisor and mentor, Dr. Ramin Pashaie, from LOCI and NITRO labs, Thomas Richner, 
Sarah Brodnik, Dr. Kevin Eliceiri, and Dr. Justin Williams. These individuals have 
helped address some of the important issues which face optogenetics as well as 
developing complex BMI systems which could someday provide robust therapeutic 
benefits to many people suffering from debilitating neurological diseases, disorders, and 
brain injuries.  
These initial device designs have shown that many complex spatiotemporal 
closed-loop control therapies for addressing brain malfunctions are feasible. With some 
technological advances in imaging and SLM technology, we could possibly design 
systems for mobile use where a patient could carry the corrective BMI with them as they 
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conduct their daily tasks. Along with the potential future therapeutic benefits of this 
research, there are many scientific questions which could be addressed by employing a 
similar device to our optogenetic BMI. One possible area of scientific research which 
could be investigated clearly and on a timescale equivalent to that of neural activity by 
using optogenetics, is the interactions between neurons within complex circuits in-vitro. 
Another interesting area of research which has become possible more feasible by 
employing a optogenetic BMI device is the construction of neural circuits, in-vitro, using 
patterned stimulation and inhibition to develop a pre-determined desired signal 
processing system. This type of research would be very similar to the work being 
conducted at the Potter Lab of Georgia Tech [58], which utilize electrode arrays to build 
connections and computational networks within populations of neurons. Instead of using 
electrodes to build these networks in-vitro the investigator would use an optogenetic BMI 
device similar to the one presented in this thesis which has spatial-temporal control of the 
stimulation and inhibition of neurons in the field of view.  
Another future application of the optogenetic BMI, given many technological 
advances in miniaturizing the imaging and projection devices, is a device which 
communicates directly to the cortex of the brain. This could include using a device to 
bypass the early sensors and circuits in the visual, motor, audio, or other sensory systems. 
There are currently devices which utilize electrodes to do restorative therapies which 
bypass human sensors and early brain circuits to provide artificial visual stimulation to 
patients who have lost their visual organs [59]. 
 By employing the use of the Monte Carlo light distribution toolbox, one can be 
sure to only alter or affect the neural activity of targeted brain tissue areas for 
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experiments where optogenetics is employed. Although our initial Monte Carlo toolbox 
will only use Sprague-Dawley rats, the same or a similar device can be used to extract the 
optical properties of other tissues.  
 While optogenetics is only in the early stages of developement, the 
spatiotemporal optogenetic BMI and the Monte Carlo toolbox for predicting light 
distribution within the brain tissue address some of the concerns and technological 
questions which, until now, have been unanswered.  
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